secwatch / observer
8-K filed May 15, 2026, 4:15 PM ET ticker AVXL CIK 0001314052
leadership confidence high sentiment neutral materiality 0.30

Anavex COO Felix Lauscher departs May 11 amid reorganization after interim CEO

ANAVEX LIFE SCIENCES CORP.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Felix Lauscher

Chief Operating Officer
AVXL · ANAVEX LIFE SCIENCES CORP.
Effective
2026-05-11
Filed
May 15, 2026, 4:15 PM ET
On May 11, 2026, Felix Lauscher, who had held the title of Chief Operating Officer of Anavex Life Sciences Corp. (the “Company”) since March 1, 2026, departed from the Company as part of a broader reorganization of duties at the Company following the appointment of Dr. Terrie Kellmeyer as the Company’s Interim Chief Executive Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Felix Lauscher departed as Chief Operating Officer at ANAVEX LIFE SCIENCES CORP..

Action
departed
Role
Chief Operating Officer
Exact text from the filing
On May 11, 2026, Felix Lauscher, who had held the title of Chief Operating Officer of Anavex Life Sciences Corp. (the “Company”) since March 1, 2026, departed from the Company as part of a broader reorganization of duties at the Company following the appointment of Dr. Terrie Kellmeyer as the Company’s Interim Chief Executive Officer.
View on SEC.gov

ANAVEX LIFE SCIENCES CORP. filing history →

Source: SEC EDGAR
accession 0001731122-26-000744
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.